Guangdong Biolight Meditech Co Ltd
Guangdong Biolight Meditech Co., Ltd. engages in the research and development, production, sale, and service of medical devices products and solutions in China. It operates in two segments, Life Information and Support, and Kidney Disease. The company offers emergency and critical care monitor, subcritical care monitor, general ward monitor, outpatient monitor, neonatal monitor, infusion pump, el… Read more
Guangdong Biolight Meditech Co Ltd (300246) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.049x
Based on the latest financial reports, Guangdong Biolight Meditech Co Ltd (300246) has a cash flow conversion efficiency ratio of 0.049x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥62.62 Million) by net assets (CN¥1.29 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Guangdong Biolight Meditech Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Guangdong Biolight Meditech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Guangdong Biolight Meditech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangdong Biolight Meditech Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhejiang Yankon Group Co Ltd
SHG:600261
|
0.022x |
|
Hyster-Yale Materials Handling Inc
NYSE:HY
|
0.067x |
|
enCore Energy Corp.
V:EU
|
-0.073x |
|
Shenzhen Etmade Automatic Equipment
SHE:300812
|
0.067x |
|
Venturex Resources Ltd (Australia)
PINK:VTEXF
|
N/A |
|
IRPC PCL -NVDR- BA 1
F:NVPF
|
N/A |
|
Finnair Oyj
PINK:FNNNF
|
0.160x |
|
E2open Parent Holdings Inc
NYSE:ETWO
|
0.046x |
Annual Cash Flow Conversion Efficiency for Guangdong Biolight Meditech Co Ltd (2008–2024)
The table below shows the annual cash flow conversion efficiency of Guangdong Biolight Meditech Co Ltd from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.29 Billion | CN¥-8.64 Million | -0.007x | -107.20% |
| 2023-12-31 | CN¥1.39 Billion | CN¥129.05 Million | 0.093x | -0.80% |
| 2022-12-31 | CN¥1.50 Billion | CN¥140.72 Million | 0.094x | +15.30% |
| 2021-12-31 | CN¥992.38 Million | CN¥80.61 Million | 0.081x | -81.59% |
| 2020-12-31 | CN¥1.03 Billion | CN¥455.78 Million | 0.441x | +217.50% |
| 2019-12-31 | CN¥585.84 Million | CN¥81.43 Million | 0.139x | +6.49% |
| 2018-12-31 | CN¥622.19 Million | CN¥81.21 Million | 0.131x | +0.02% |
| 2017-12-31 | CN¥554.08 Million | CN¥72.31 Million | 0.130x | +29.53% |
| 2016-12-31 | CN¥504.27 Million | CN¥50.81 Million | 0.101x | +63.51% |
| 2015-12-31 | CN¥460.87 Million | CN¥28.40 Million | 0.062x | -37.68% |
| 2014-12-31 | CN¥427.94 Million | CN¥42.31 Million | 0.099x | +42.54% |
| 2013-12-31 | CN¥393.88 Million | CN¥27.32 Million | 0.069x | -35.30% |
| 2012-12-31 | CN¥377.93 Million | CN¥40.52 Million | 0.107x | +30.72% |
| 2011-12-31 | CN¥354.32 Million | CN¥29.06 Million | 0.082x | -81.60% |
| 2010-12-31 | CN¥89.93 Million | CN¥40.09 Million | 0.446x | +73.55% |
| 2009-12-31 | CN¥66.94 Million | CN¥17.19 Million | 0.257x | -5.70% |
| 2008-12-31 | CN¥46.53 Million | CN¥12.68 Million | 0.272x | -- |